Stock BIO BIOFARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biofarm S.A.

Equities

BIO

ROBIOFACNOR9

Pharmaceuticals

End-of-day quote Bucharest S.E.
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
0.822 RON -0.48% Intraday chart for Biofarm S.A. -0.96% -0.24%
02-28 Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 320.2 357.7 421.7 821.8 607 811.9
Enterprise Value (EV) 1 274.6 266.6 346.2 717.9 524.3 700.3
P/E ratio 8.9 x 7.53 x 8.34 x 14.7 x 9.31 x 11.6 x
Yield 6.15% 5.79% 5.14% 2.88% 4.87% 3.76%
Capitalization / Revenue 1.74 x 1.83 x 1.95 x 3.44 x 2.19 x 2.9 x
EV / Revenue 1.49 x 1.36 x 1.6 x 3 x 1.89 x 2.5 x
EV / EBITDA 4.69 x 3.86 x 4.64 x 8.69 x 5.55 x 7.63 x
EV / FCF 8.76 x 5.06 x -34.6 x 17.7 x -26.3 x 20.3 x
FCF Yield 11.4% 19.8% -2.89% 5.64% -3.81% 4.93%
Price to Book 1.42 x 1.39 x 1.45 x 2.47 x 1.6 x 1.87 x
Nbr of stocks (in thousands) 985,367 985,367 985,367 985,367 985,367 985,367
Reference price 2 0.3250 0.3630 0.4280 0.8340 0.6160 0.8240
Announcement Date 19/06/19 28/04/20 26/04/21 28/04/22 26/04/23 24/04/24
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 184.2 195.3 216.4 239 277 280.3
EBITDA 1 58.56 69.14 74.62 82.59 94.45 91.77
EBIT 1 46.5 60.91 63.67 68.87 78.95 74.81
Operating Margin 25.24% 31.18% 29.42% 28.81% 28.51% 26.69%
Earnings before Tax (EBT) 1 47.17 62.47 64.85 69.55 80.88 83.71
Net income 1 38.42 50.88 54.26 60.36 70.92 77.01
Net margin 20.86% 26.05% 25.07% 25.25% 25.6% 27.48%
EPS 2 0.0365 0.0482 0.0513 0.0569 0.0662 0.0713
Free Cash Flow 1 31.34 52.69 -9.998 40.47 -19.96 34.51
FCF margin 17.01% 26.97% -4.62% 16.93% -7.21% 12.31%
FCF Conversion (EBITDA) 53.51% 76.2% - 49% - 37.6%
FCF Conversion (Net income) 81.55% 103.55% - 67.06% - 44.81%
Dividend per Share 2 0.0200 0.0210 0.0220 0.0240 0.0300 0.0310
Announcement Date 19/06/19 28/04/20 26/04/21 28/04/22 26/04/23 24/04/24
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 45.6 91.1 75.5 104 82.7 112
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 31.3 52.7 -10 40.5 -20 34.5
ROE (net income / shareholders' equity) 17.4% 21.1% 19.8% 19.3% 19.9% 18.9%
ROA (Net income/ Total Assets) 10.6% 12% 11.1% 10.9% 11.1% 9.74%
Assets 1 362.2 422.4 490.2 554.7 636.2 790.9
Book Value Per Share 2 0.2300 0.2600 0.3000 0.3400 0.3900 0.4400
Cash Flow per Share 2 0.0500 0.0900 0.0600 0.1100 0.0800 0.0200
Capex 1 20.9 19.8 27.5 21.5 30.1 29.8
Capex / Sales 11.32% 10.13% 12.7% 8.97% 10.88% 10.65%
Announcement Date 19/06/19 28/04/20 26/04/21 28/04/22 26/04/23 24/04/24
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOFARM S.A. Stock Biofarm S.A.
-0.24% 174M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.16% 43.75B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+27.47% 22.06B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.30% 14.46B
CIPLA LIMITED Stock Cipla Limited
+13.03% 13.62B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.58% 11.61B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.54% 6.9B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+9.64% 5.32B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BIO Stock
  4. Financials Biofarm S.A.